Growth Perspectives: Key Highlights from DCAT 2024
Frost & Sullivan
APRIL 3, 2024
FUJIFILM Diosynth Biotechnologies invested $1.6 Growth Opportunity 2 – Medical Cannabidiol (CBD) Global regulatory shifts toward legalizing medical cannabis and CBD products highlight the growing interest in cannabis-based treatments.
Let's personalize your content